Clover Health Investments (CLOV) Competitors

Clover Health Investments logo
$5.06 -0.08 (-1.56%)
Closing price 04:00 PM Eastern
Extended Trading
$5.06 0.00 (-0.10%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CLOV vs. RYAN, OSCR, VOYA, JXN, and KNSL

Should you buy Clover Health Investments stock or one of its competitors? MarketBeat compares Clover Health Investments with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Clover Health Investments include Ryan Specialty (RYAN), Oscar Health (OSCR), Voya Financial (VOYA), Jackson Financial (JXN), and Kinsale Capital Group (KNSL). These companies are all part of the "insurance" industry.

How does Clover Health Investments compare to Ryan Specialty?

Ryan Specialty (NYSE:RYAN) and Clover Health Investments (NASDAQ:CLOV) are both mid-cap insurance companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations, institutional ownership and media sentiment.

In the previous week, Clover Health Investments had 1 more articles in the media than Ryan Specialty. MarketBeat recorded 6 mentions for Clover Health Investments and 5 mentions for Ryan Specialty. Ryan Specialty's average media sentiment score of 1.47 beat Clover Health Investments' score of 0.35 indicating that Ryan Specialty is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ryan Specialty
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Clover Health Investments
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Ryan Specialty has a net margin of 8.21% compared to Clover Health Investments' net margin of -2.58%. Ryan Specialty's return on equity of 41.33% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Ryan Specialty8.21% 41.33% 4.80%
Clover Health Investments -2.58%-16.52%-9.28%

Ryan Specialty has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ryan Specialty$3.05B2.98$63.40M$0.7744.75
Clover Health Investments$1.92B1.38-$85.55M-$0.12N/A

Ryan Specialty presently has a consensus target price of $47.12, indicating a potential upside of 36.73%. Clover Health Investments has a consensus target price of $3.82, indicating a potential downside of 24.57%. Given Ryan Specialty's stronger consensus rating and higher possible upside, research analysts clearly believe Ryan Specialty is more favorable than Clover Health Investments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ryan Specialty
3 Sell rating(s)
7 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.37
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

84.8% of Ryan Specialty shares are held by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are held by institutional investors. 52.0% of Ryan Specialty shares are held by company insiders. Comparatively, 23.5% of Clover Health Investments shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Ryan Specialty has a beta of 0.64, meaning that its stock price is 36% less volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.54, meaning that its stock price is 154% more volatile than the broader market.

Summary

Ryan Specialty beats Clover Health Investments on 14 of the 16 factors compared between the two stocks.

How does Clover Health Investments compare to Oscar Health?

Oscar Health (NYSE:OSCR) and Clover Health Investments (NASDAQ:CLOV) are both mid-cap insurance companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, institutional ownership, risk, profitability and earnings.

Oscar Health has a beta of 2.37, indicating that its stock price is 137% more volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.54, indicating that its stock price is 154% more volatile than the broader market.

Clover Health Investments has lower revenue, but higher earnings than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than Clover Health Investments, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oscar Health$11.70B0.77-$443.15M-$0.59N/A
Clover Health Investments$1.92B1.38-$85.55M-$0.12N/A

In the previous week, Oscar Health and Oscar Health both had 6 articles in the media. Oscar Health's average media sentiment score of 1.06 beat Clover Health Investments' score of 0.35 indicating that Oscar Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oscar Health
4 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Clover Health Investments
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Oscar Health has a net margin of -0.30% compared to Clover Health Investments' net margin of -2.58%. Oscar Health's return on equity of -3.26% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Oscar Health-0.30% -3.26% -0.57%
Clover Health Investments -2.58%-16.52%-9.28%

75.7% of Oscar Health shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 25.1% of Oscar Health shares are owned by insiders. Comparatively, 23.5% of Clover Health Investments shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Oscar Health currently has a consensus price target of $20.78, indicating a potential downside of 30.69%. Clover Health Investments has a consensus price target of $3.82, indicating a potential downside of 24.57%. Given Clover Health Investments' higher probable upside, analysts clearly believe Clover Health Investments is more favorable than Oscar Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oscar Health
1 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.17
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Oscar Health beats Clover Health Investments on 9 of the 14 factors compared between the two stocks.

How does Clover Health Investments compare to Voya Financial?

Clover Health Investments (NASDAQ:CLOV) and Voya Financial (NYSE:VOYA) are both mid-cap insurance companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation, risk and media sentiment.

19.8% of Clover Health Investments shares are held by institutional investors. Comparatively, 96.1% of Voya Financial shares are held by institutional investors. 23.5% of Clover Health Investments shares are held by company insiders. Comparatively, 1.6% of Voya Financial shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Voya Financial has a net margin of 8.24% compared to Clover Health Investments' net margin of -2.58%. Voya Financial's return on equity of 13.84% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Clover Health Investments-2.58% -16.52% -9.28%
Voya Financial 8.24%13.84%0.52%

Clover Health Investments presently has a consensus price target of $3.82, suggesting a potential downside of 24.57%. Voya Financial has a consensus price target of $91.73, suggesting a potential downside of 0.52%. Given Voya Financial's stronger consensus rating and higher probable upside, analysts clearly believe Voya Financial is more favorable than Clover Health Investments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Voya Financial
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.75

Voya Financial has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Voya Financial, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clover Health Investments$1.92B1.38-$85.55M-$0.12N/A
Voya Financial$8.19B1.02$654M$6.6213.93

Clover Health Investments has a beta of 2.54, indicating that its stock price is 154% more volatile than the broader market. Comparatively, Voya Financial has a beta of 0.92, indicating that its stock price is 8% less volatile than the broader market.

In the previous week, Clover Health Investments had 3 more articles in the media than Voya Financial. MarketBeat recorded 6 mentions for Clover Health Investments and 3 mentions for Voya Financial. Voya Financial's average media sentiment score of 0.65 beat Clover Health Investments' score of 0.35 indicating that Voya Financial is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Clover Health Investments
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Voya Financial
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Voya Financial beats Clover Health Investments on 12 of the 16 factors compared between the two stocks.

How does Clover Health Investments compare to Jackson Financial?

Jackson Financial (NYSE:JXN) and Clover Health Investments (NASDAQ:CLOV) are both mid-cap insurance companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, earnings and dividends.

In the previous week, Clover Health Investments had 5 more articles in the media than Jackson Financial. MarketBeat recorded 6 mentions for Clover Health Investments and 1 mentions for Jackson Financial. Jackson Financial's average media sentiment score of 1.11 beat Clover Health Investments' score of 0.35 indicating that Jackson Financial is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Jackson Financial
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Clover Health Investments
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Jackson Financial currently has a consensus target price of $115.80, suggesting a potential upside of 5.51%. Clover Health Investments has a consensus target price of $3.82, suggesting a potential downside of 24.57%. Given Jackson Financial's stronger consensus rating and higher probable upside, equities research analysts plainly believe Jackson Financial is more favorable than Clover Health Investments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jackson Financial
0 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.43
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Jackson Financial has a beta of 1.32, indicating that its share price is 32% more volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.54, indicating that its share price is 154% more volatile than the broader market.

90.0% of Jackson Financial shares are held by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are held by institutional investors. 1.4% of Jackson Financial shares are held by company insiders. Comparatively, 23.5% of Clover Health Investments shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Jackson Financial has a net margin of 0.00% compared to Clover Health Investments' net margin of -2.58%. Jackson Financial's return on equity of 17.21% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Jackson FinancialN/A 17.21% 0.49%
Clover Health Investments -2.58%-16.52%-9.28%

Jackson Financial has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Jackson Financial, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jackson Financial$6.68B1.15$27M-$6.11N/A
Clover Health Investments$1.92B1.38-$85.55M-$0.12N/A

Summary

Jackson Financial beats Clover Health Investments on 10 of the 15 factors compared between the two stocks.

How does Clover Health Investments compare to Kinsale Capital Group?

Kinsale Capital Group (NYSE:KNSL) and Clover Health Investments (NASDAQ:CLOV) are both mid-cap insurance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings, media sentiment and profitability.

Kinsale Capital Group currently has a consensus target price of $374.90, suggesting a potential upside of 22.99%. Clover Health Investments has a consensus target price of $3.82, suggesting a potential downside of 24.57%. Given Kinsale Capital Group's higher possible upside, research analysts plainly believe Kinsale Capital Group is more favorable than Clover Health Investments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kinsale Capital Group
2 Sell rating(s)
8 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.91
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

85.4% of Kinsale Capital Group shares are held by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are held by institutional investors. 5.6% of Kinsale Capital Group shares are held by insiders. Comparatively, 23.5% of Clover Health Investments shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Kinsale Capital Group had 2 more articles in the media than Clover Health Investments. MarketBeat recorded 8 mentions for Kinsale Capital Group and 6 mentions for Clover Health Investments. Kinsale Capital Group's average media sentiment score of 1.00 beat Clover Health Investments' score of 0.35 indicating that Kinsale Capital Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kinsale Capital Group
5 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Clover Health Investments
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Kinsale Capital Group has a beta of 0.91, suggesting that its stock price is 9% less volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.54, suggesting that its stock price is 154% more volatile than the broader market.

Kinsale Capital Group has higher earnings, but lower revenue than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Kinsale Capital Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kinsale Capital Group$1.87B3.75$503.61M$22.7213.42
Clover Health Investments$1.92B1.38-$85.55M-$0.12N/A

Kinsale Capital Group has a net margin of 27.48% compared to Clover Health Investments' net margin of -2.58%. Kinsale Capital Group's return on equity of 25.82% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Kinsale Capital Group27.48% 25.82% 8.20%
Clover Health Investments -2.58%-16.52%-9.28%

Summary

Kinsale Capital Group beats Clover Health Investments on 10 of the 14 factors compared between the two stocks.

Get Clover Health Investments News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLOV and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLOV vs. The Competition

MetricClover Health InvestmentsMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$2.71B$1.56B$6.46B$12.11B
Dividend YieldN/AN/A2.68%5.81%
P/E RatioN/A77.6624.7124.00
Price / Sales1.386.83492.4790.40
Price / CashN/A23.7727.9237.84
Price / Book8.585.1610.826.53
Net Income-$85.55M-$54.76M$3.56B$336.99M
7 Day Performance2.43%-1.75%1.67%-0.22%
1 Month Performance42.54%-3.64%0.43%0.77%
1 Year Performance78.80%-1.78%32.84%31.57%

Clover Health Investments Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLOV
Clover Health Investments
1.4685 of 5 stars
$5.06
-1.6%
$3.82
-24.6%
+70.2%$2.71B$1.92BN/A680
RYAN
Ryan Specialty
4.9777 of 5 stars
$35.35
-0.8%
$47.12
+33.3%
-50.3%$9.40B$3.05B45.916,110
OSCR
Oscar Health
3.4939 of 5 stars
$29.08
+2.9%
$20.78
-28.6%
+34.1%$8.52B$11.70BN/A2,305
VOYA
Voya Financial
4.6591 of 5 stars
$91.12
-0.4%
$91.73
+0.7%
+38.3%$8.29B$8.19B13.7611,000
JXN
Jackson Financial
1.6718 of 5 stars
$109.70
+0.9%
$115.80
+5.6%
+28.8%$7.58B$6.68BN/A3,890

Related Companies and Tools


This page (NASDAQ:CLOV) was last updated on 6/23/2026 by MarketBeat.com Staff.
From Our Partners